Your browser doesn't support javascript.
loading
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.
Holmgren, Johanna; Fröborg, Anna; Visuri, Isabella; Halfvarson, Jonas; Hjortswang, Henrik; Karling, Pontus; Myrelid, Pär; Olén, Ola; Ludvigsson, Jonas F; Grip, Olof.
Affiliation
  • Holmgren J; Skåne University Hospital, Department of Gastroenterology, Malmö, Sweden.
  • Fröborg A; Section of Medicine, Department of Clinical sciences, Lund University, Malmö, Sweden.
  • Visuri I; Karlskrona Hospital, Department of Ear, Nose and Throat Diseases, Karlskrona, Sweden.
  • Halfvarson J; Örebro University, Department of Gastroenterology, Faculty of Medicine and Health, Örebro, Sweden.
  • Hjortswang H; Örebro University, Department of Gastroenterology, Faculty of Medicine and Health, Örebro, Sweden.
  • Karling P; Linköping University, Department of Biomedical and Clinical Sciences, Linköping, Sweden.
  • Myrelid P; Linköping University, Department of Gastroenterology, Linköping, Sweden.
  • Olén O; Umeå University, Department of Public Health and Clinical Medicine, Umeå, Sweden.
  • Ludvigsson JF; Linköping University Hospital, Department of Surgery, Linköping, Sweden.
  • Grip O; Karolinska Institutet, Clinical Epidemiology Unit, Department of Medicine Solna, Stockholm, Sweden.
Inflamm Bowel Dis ; 29(3): 339-348, 2023 03 01.
Article in En | MEDLINE | ID: mdl-35776552
The incidence rate of serious infection among inflammatory bowel disease patients did not increase with anti-TNF therapy compared with 1 year before treatment start. A decrease in incidence rate could be seen more than 1 year after initiation of anti-TNF.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido